摘要
Background： Giant cell tumors （GCTs） are benign, locally aggressive tumors. We exalnined the rate of local rectirrence of spinal GCTs and sought to identify recurrence factors in patients who underwent surgery. Methods： Between 1995 and 2014, 94 mobile spine GCT patients were treated at our hospital, comprising 43 male and 51 female patients with an average age of 33.4 years. Piecemeal intralesional spondylectomy and total en bloc spondylectomy （TES） were performed. Radiotherapy was suggested for recurrent or residual GCT cases. Since denosumab was not available before 2014 in our country, only interferon and/or zoledronic acid was suggested. Results： Of the 94 patients, four underwent conservative treatment and 90 underwent operations. Seventy-five patients （79.8%） were followed tip for a minimum of 24 months or until death. The median follow-up duration was 75.3 months. The overall recurrence rate was 37.3%. Ten patients （13.3%） died before the last follow-up （rnedian： 18.5 months）. Two patients （2.6%） developed osteogenic sarcoma. The local recurrence rate was 80.0% （24/30） in patients who underwent intralesional curettage, 8.8% （3/34） in patients who underwent extracapsular piecemeal spondylectomy,and 0 （0/9） in patients who underwent TES. The risk factors for local recurrence were lesions located in the cervical spine （P = 0.049）, intralesional curettage （P 〈 0.001 ）, repeated surgeries （P 0.014）, and malignancy （P 〈 0.001 ）. Malignant transformation was a significant risk factor for death （P 〈 0.001 ）. Conclusions： Cervical spinal tumors, curettage, and nonintact tumors were risk l;actors for local recurrence. Intralesional curettage and malignancy were the most important significant factors for local rectirrence and death, respectively.
Background： Giant cell tumors （GCTs） are benign, locally aggressive tumors. We exalnined the rate of local rectirrence of spinal GCTs and sought to identify recurrence factors in patients who underwent surgery. Methods： Between 1995 and 2014, 94 mobile spine GCT patients were treated at our hospital, comprising 43 male and 51 female patients with an average age of 33.4 years. Piecemeal intralesional spondylectomy and total en bloc spondylectomy （TES） were performed. Radiotherapy was suggested for recurrent or residual GCT cases. Since denosumab was not available before 2014 in our country, only interferon and/or zoledronic acid was suggested. Results： Of the 94 patients, four underwent conservative treatment and 90 underwent operations. Seventy-five patients （79.8%） were followed tip for a minimum of 24 months or until death. The median follow-up duration was 75.3 months. The overall recurrence rate was 37.3%. Ten patients （13.3%） died before the last follow-up （rnedian： 18.5 months）. Two patients （2.6%） developed osteogenic sarcoma. The local recurrence rate was 80.0% （24/30） in patients who underwent intralesional curettage, 8.8% （3/34） in patients who underwent extracapsular piecemeal spondylectomy,and 0 （0/9） in patients who underwent TES. The risk factors for local recurrence were lesions located in the cervical spine （P = 0.049）, intralesional curettage （P 〈 0.001 ）, repeated surgeries （P 0.014）, and malignancy （P 〈 0.001 ）. Malignant transformation was a significant risk factor for death （P 〈 0.001 ）. Conclusions： Cervical spinal tumors, curettage, and nonintact tumors were risk l;actors for local recurrence. Intralesional curettage and malignancy were the most important significant factors for local rectirrence and death, respectively.
